Griseofulvin, microcrystalline - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for griseofulvin, microcrystalline and what is the scope of freedom to operate?
Griseofulvin, microcrystalline
is the generic ingredient in two branded drugs marketed by Wyeth Ayerst, Johnson And Johnson, J And J, and Valeant Luxembourg, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.Summary for griseofulvin, microcrystalline
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 4 |
| NDAs: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 96 |
| Patent Applications: | 7,529 |
| DailyMed Link: | griseofulvin, microcrystalline at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for griseofulvin, microcrystalline
US Patents and Regulatory Information for griseofulvin, microcrystalline
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | GRISACTIN | griseofulvin, microcrystalline | TABLET;ORAL | 060212-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| J And J | GRIFULVIN V | griseofulvin, microcrystalline | TABLET;ORAL | 060618-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Valeant Luxembourg | GRIFULVIN V | griseofulvin, microcrystalline | TABLET;ORAL | 062279-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
